{"role": "assistant", "content": null, "function_call": {"name": "get_risks", "arguments": "{\"risks\":[{\"Description\":\"Potential spread of antibiotic-resistant bacteria due to misclassification of bacterial protective antigens (BPAs) by AI in reverse vaccinology.\",\"Impact\":\"Increased resistance to existing antibiotics and difficulty in treating bacterial infections.\",\"Mitigation\":\"Regular screening for antibiotic-resistant strains, validation and verification of AI predictions.\",\"Technologies\":\"Machine learning algorithms, genetic sequencing tools.\",\"People\":\"General population, healthcare providers, patients with bacterial infections.\",\"Owner\":\"Healthcare organizations, pharmaceutical companies, research institutions.\"},{\"Description\":\"Misidentification or misinterpretation of clinical trial outcomes by AI, leading to incorrect drug development decisions.\",\"Impact\":\"Unsafe or ineffective drugs being released to the market, potential harm to patients.\",\"Mitigation\":\"Independent validation of AI predictions, rigorous testing and evaluation of AI-assisted drug development.\",\"Technologies\":\"Artificial intelligence, data analysis platforms.\",\"People\":\"Patients, healthcare providers, pharmaceutical companies.\",\"Owner\":\"Regulatory agencies, pharmaceutical companies, research institutions.\"},{\"Description\":\"Inaccurate prediction of ventilator settings by ML, impacting patient treatment and respiratory illness management.\",\"Impact\":\"Suboptimal treatment, increased risk of complications for ventilated patients.\",\"Mitigation\":\"Regular calibration and validation of ML algorithms, manual verification of ventilator settings by healthcare professionals.\",\"Technologies\":\"Machine learning algorithms, medical sensors.\",\"People\":\"Ventilated patients, healthcare providers, medical device manufacturers.\",\"Owner\":\"Healthcare organizations, medical device manufacturers, research institutions.\"}]}"}}